Noninvasive staging of non-small cell lung cancer: A review of the current evidence

Chest

Volumn 123, Issue 1 SUPPL., 2003, Pages 137S-146S

  Toloza, Eric M ^a   Harpole, Linda ^a   McCrory, Douglas C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CT; Lung neoplasms; Meta analysis; Predictive value of tests; Radiograph; Sensitivity; Specificity

Indexed keywords

RADIOISOTOPE;

ABDOMINAL SCINTISCANNING; ADRENAL GLAND; ARTICLE; BLOOD ANALYSIS; BONE SCINTISCANNING; BRAIN METASTASIS; BRAIN SCINTISCANNING; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL EXAMINATION; COCHRANE LIBRARY; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MEDIASTINUM CANCER; MEDIASTINUM METASTASIS; MEDLINE; METASTASIS; NEUROLOGIC EXAMINATION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PUBLICATION; SENSITIVITY AND SPECIFICITY; STANDARD; SYMPTOM;

EID: 0037246754     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717
2. Fleming ID, Cooper JS, Henson DE, et al. AJCC cancer staging handbook. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1998
3. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47
4. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer: a meta-analysis. Am J Respir Crit Care Med 1995; 152:225-230
5. Lau J. Meta-test, version 0.6. Boston, MA: New England Medical Center, 1997
6. Hasselblad V, Eddy DM. FAST*PRO: software for meta-analysis by the confidence profile method, version 1.8. Boston, MA: Academic Press, 1992
7. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12:1293-1316
8. Dunagan DP, Chin R, McCain TW, et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 2001; 119:333-339
9. Kamiyoshihara M, Kawashima O, Ishikawa S, et al. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer. J Cardiovasc Surg (Torino) 2001; 42:119-124
10. Osada H, Kojima K, Tsukada H, et al. Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer. Jpn J Thorac Cardiovasc Surg 2001; 49:1-10
11. Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343:254-261
12. Takamochi K, Nagai K, Yoshida J, et al. The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer. Thorac Cardiovasc Surg 2000; 119:1135-1140
13. Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212:803-809
14. Saunders CA, Dussek JE, O'Doherty MJ, et al. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 1999; 67:790-797
15. Suzuki K, Nagai K, Yoshida J, et al. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. Thorac Cardiovasc Surg 1999; 117:593-598
16. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16:2142-2149
17. Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?; the Leuven Lung Cancer Group. Eur J Nucl Med 1998; 25:1495-1501
18. Bury T, Dowlati A, Paulus P, et al. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. Eur Respir J 1997; 10:2529-2534
19. Gdeedo A, Van Schil P, Corthouts B, et al. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J 1997; 10:1547-1551
20. Buccheri G, Biggi A, Ferrigno D, et al. Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer. Thorax 1996; 51:359-363
21. Bury T, Paulus P, Dowlati A, et al. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. Eur Respir J 1996; 9:2560-2564
22. Aaby C, Kristensen S, Nielsen SM. Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy. ORL J Otorhinolaryngol Relat Spec 1995; 57:279-285
23. Primack SL, Lee KS, Logan PM, et al. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994; 193:795-800
24. Yokoi K, Okuyama A, Mori K, et al. Mediastinal lymph node metastasis from lung cancer: evaluation with Tl-201 SPECT; comparison with CT. Radiology 1994; 192:813-817
25. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323
26. Jolly PC, Hutchinson CH, Detterbeck F, et al. Routine computed tomographic scans, selective mediastinoscopy, and other factors in evaluation of lung cancer. Thorac Cardiovasc Surg 1991; 102:266-270
27. Cole PH, Roszkowski A, Firouz-Abadi A, et al. Computerised tomography does not predict N2 disease in patients with lung cancer. Aust N Z J Med 1993; 23:688-691
28. Farrell MA, McAdams HP, Herndon JE, et al. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 2000; 215:886-890
29. Liewald F, Grosse S, Storck M, et al. How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer? Thorac Cardiovasc Surg 2000; 48:93-96
30. Roberts PF, Follette DM, von Haag D, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000; 70:1154-1159
31. Magnani P, Carretta A, Rizzo G, et al. FDG/PET, and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg (Torino) 1999; 40:741-748
32. Guhlmann A, Storck M, Kotzerke J, et al. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). Thorax 1997; 52:438-441
33. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET vs CT with correlative lymph node mapping and sampling. Radiology 1997; 202:441-446
34. Sazon DA, Santiago SM, Soo Hoo GW, et al. Fluorodeoxy-glucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996; 153:417-421
35. Scott WJ, Gobar LS, Terry JD, et al. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. Thorac Cardiovasc Surg 1996; 111:642-648
36. Chin R Jr, Ward R, Keyes JW, et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995; 152:2090-2096
37. Wahl RL, Quint LE, Greenough RL, et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191:371-377
38. Crisci R, Di Cesare E, Lupattelli L, et al. MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA. Eur J Cardiothorac Surg 1997; 11:214-217
39. Wiersema MJ, Vazquez-Sequeiros E, Wiersema LM. Evaluation of mediastinal lymphadenopathy with endoscopic US-guided fine-needle aspiration biopsy. Radiology 2001; 219:252-257
40. Gress FG, Savides TJ, Sandler A, et al. Endoscopic ultrasonography, fine-needle aspiration biopsy guided by endoscopic ultrasonography, and computed tomography in the preoperative staging of non-small-cell lung cancer: a comparison study. Ann Intern Med 1997; 127:604-612
41. Potepan P, Meroni E, Spagnoli I, et al. Non-small-cell lung cancer: detection of mediastinal lymph node metastases by endoscopic ultrasound and CT. Eur Radiol 1996; 6:19-24
42. Silvestri GA, Hoffman BJ, Bhutani MS, et al. Endoscopic ultrasound with fine-needle aspiration in the diagnosis and staging of lung cancer. Ann Thorac Surg 1996; 61:1441-1445
43. Schuder G, Isringhaus H, Kubale B, et al. Endoscopic ultrasonography of the mediastinum in the diagnosis of bronchial carcinoma. Thorac Cardiovasc Surg 1991; 39:299-303
44. Yokoi K, Kamiya N, Matsuguma H, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 1999; 115:714-719
45. Cole FH Jr, Thomas JE, Wilcox AB, et al. Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: is it worthwhile? Ann Thorac Surg 1994; 57:838-840
46. Habets JM, van Oosterhout AG, ten Velde GP, et al. Diagnostic value of CT in the detection of brain metastasis in small cell lung cancer patients. J Belge Radiol 1992; 75:179-181
47. Kormas P, Bradshaw JR, Jeyasingham K. Preoperative computed tomography of the brain in non-small cell bronchogenic carcinoma. Thorax 1992; 47:106-108
48. Salvatierra A, Baamonde C, Llamas JM, et al. Extrathoracic staging of bronchogenic carcinoma. Chest 1990; 97:1052-1058
49. Grant D, Edwards D, Goldstraw P. Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer. Thorax 1988; 43:883-886
50. Osada H, Nakajima Y, Taira Y, et al. The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer. Jpn J Surg 1987; 17:362-368
51. Crane JM, Nelson MJ, Ihde DC, et al. A comparison of computed tomography and radionuclide scanning for detection of brain metastases in small cell lung cancer. J Clin Oncol 1984; 2:1017-1024
52. Hooper RG, Tenholder MF, Underwood GH, et al. Computed tomographic scanning of the brain in initial staging of bronchogenic carcinoma. Chest 1984; 85:774-776
53. Levitan N, Hong WK, Byrne RE, et al. Role of computerized cranial tomography in the staging of small cell carcinoma of the lung. Cancer Treat Rep 1984; 68:1375-1377
54. Mintz BJ, Tuhrim S, Alexander S, et al. Intracranial metastases in the initial staging of bronchogenic carcinoma. Chest 1984; 86:850-853
55. Tarver RD, Richmond BD, Klatte EC. Cerebral metastases from lung carcinoma: neurological and CT correlation: work in progress. Radiology 1984; 153:689-692
56. Johnson DH, Windham WW, Allen JH, et al. Limited value of CT brain scans in the staging of small cell lung cancer. AJR Am J Roentgenol 1983; 140:37-40
57. Jennings EC, Aungst CW, Yatco R. Asymptomatic patients with primary carcinoma; computerized axial tomography study. N Y State J Med 1980; 80:1096-1098
58. Butler AR, Leo JS, Lin JP, et al. The value of routine cranial computed tomography in neurologically intact patients with primary carcinoma of the lung. Radiology 1979; 131:399-401
59. Jacobs L, Kinkel WR, Vincent RG. "Silent" brain metastasis from lung carcinoma determined by computerized tomography. Arch Neurol 1977; 34:690-693
60. Miralles TG, Gosabez F, de Lera J, et al. Percutaneous fine needle aspiration biopsy cytology of the liver for staging small cell lung carcinoma: comparison with other methods. Acta Cytol 1993; 37:499-502
61. Silvestri GA, Lenz JE, Harper SN, et al. The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. Chest 1992; 102:1748-1751
62. Ettinghausen SE, Burt ME. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. J Clin Oncol 1991; 9:1462-1466
63. Whittlesey D. Prospective computed tomographic scanning in the staging of bronchogenic cancer. Thorac Cardiovasc Surg 1988; 95:876-882
64. Mirvis SE, Whitley NO, Aisner J, et al. Abdominal CT in the staging of small-cell carcinoma of the lung: incidence of metastases and effect on prognosis. AJR Am J Roentgenol 1987; 148:845-847
65. Heavey LR, Glazer GM, Gross BH, et al. The role of CT in staging radiographic T1N0M0 lung cancer. AJR Am J Roentgenol 1986; 146:285-290
66. Pearlberg JL, Sandler MA, Beute GH, et al. T1N0M0 bronchogenic carcinoma: assessment by CT. Radiology 1985; 157:187-190
67. Chapman GS, Kumar D, Redmond J 3rd, et al. Upper abdominal computerized tomography scanning in staging non-small cell lung carcinoma. Cancer 1984; 54:1541-1543
68. Nielsen ME, Heaston DK, Dunnick NR, et al. Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma. AJR Am J Roentgenol 1982; 139:317-320
69. Michel F, Soler M, Imhof E, et al. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. Thorax 1991; 46:469-473
70. Tornyos K, Garcia O, Karr B, et al. A correlation study of bone scanning with clinical and laboratory findings in the staging of nonsmall-cell lung cancer. Clin Nucl Med 1991; 16:107-109
71. Turner P, Haggith JW. Preoperative radionuclide scanning in bronchogenic carcinoma. Br J Dis Chest 1981; 75:291-294
72. Hooper RG, Beechler CR, Johnson MC. Radioisotope scanning in the initial staging of bronchogenic carcinoma. Am Rev Respir Dis 1978; 118:279-286
73. Ramsdell JW, Peters RM, Taylor AT Jr, et al. Multiorgan scans for staging lung cancer: correlation with clinical evaluation. Thorac Cardiovasc Surg 1977; 73:653-659
74. Canadian Lung Oncology Group. Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer. Ann Thorac Surg 2001; 71:425-434
75. Tanaka K, Kubota K, Kodama T, et al. Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1-2N0. Ann Thorac Surg 1999; 68:1039-1042
76. Hillers TK, Sauve MD, Guyatt GH. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax 1994; 49:14-19
77. Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s; meta-analytic comparison of PET and CT. Radiology 1999; 213:530-536
78. Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med 2000; 27:1598-1609
79. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359:1388-1393
80. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer: approaching a controversy using meta-analysis. Am Rev Respir Dis 1990; 141:1096-1101